Antiangiogenic and Antifibrotic Gene Therapy in a Chronic Infusion Model of Peritoneal Dialysis in Rats
| Autor: | Jack Gauldie, Catherine M. Hoff, Peter J. Margetts, Clifford J. Holmes, Steve Gyorffy, Martin Kolb, Lisa Yu |
|---|---|
| Rok vydání: | 2002 |
| Předmět: |
medicine.medical_specialty
Time Factors Decorin medicine.medical_treatment Peritoneal dialysis Dialysis tubing Rats Sprague-Dawley Internal medicine medicine Animals Subcutaneous port Vascular Diseases Angiostatins Peritoneal Fibrosis Dialysis Extracellular Matrix Proteins Catheter insertion Angiostatin Neovascularization Pathologic business.industry Plasminogen Genetic Therapy General Medicine Fibrosis Peptide Fragments Rats Endocrinology Nephrology Blood Vessels Proteoglycans Peritoneum Safety business Peritoneal Dialysis |
| Zdroj: | Journal of the American Society of Nephrology. 13:721-728 |
| ISSN: | 1046-6673 |
| DOI: | 10.1681/asn.v133721 |
| Popis: | To identify the relative importance of peritoneal fibrosis and angiogenesis in peritoneal membrane dysfunction, adenoviral mediated gene transfer of angiostatin, a recognized angiogenesis inhibitor, and decorin, a transforming growth factor-beta-inhibiting proteoglycan, were used in a daily infusion model of peritoneal dialysis. A peritoneal catheter and subcutaneous port were inserted in rats. Five and fourteen d after insertion, adenovirus-expressing angiostatin, decorin, or AdDL70, a null control virus, were administered. Daily infusion of 4.25% Baxter Dianeal was initiated 7 d after catheter insertion and continued until day 35. Three initial doses of lipopolysaccharide were administered on days 8, 10, and 12 to promote an inflammatory response. Net ultrafiltration was used as a measure of membrane function, and peritoneum-associated vasculature and mesenteric collagen content was quantified. Ultrafiltration dysfunction, angiogenesis, and fibrosis were observed in daily infusion control animals. Animals treated with AdAngiostatin demonstrated an improvement in net ultrafiltration (-3.1 versus -7.8 ml for control animals; P = 0.0004) with a significant reduction in vessel density. AdDecorin-treated animals showed a reduction in mesenteric collagen content (1.8 versus 2.9 microg/mg; P = 0.04); however, AdDecorin treatment had no effect on net ultrafiltration. In a rodent model of peritoneal membrane failure, net ultrafiltration was significantly improved and peritoneal-associated blood vessels were significantly reduced by using adenovirus-mediated gene transfer of angiostatin. Decorin, a transforming growth factor-beta-inhibiting proteoglycan, reduced collagen content but did not affect net ultrafiltration. Improvement in the function of the peritoneum as a dialysis membrane after treatment with angiostatin has implications for treatment of peritoneal membrane dysfunction seen in patients on long-term dialysis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|